Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

New NIIMBL Whitepaper Addresses Innovation for Today’s Biopharma Talent Pipeline

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) issues Innovation of the Biopharmaceutical Manufacturing Talent Pipeline, a whitepaper addressing the innovation needs and concerns fueling the employment gap in the biopharmaceutical manufacturing industry. The whitepaper proposes solutions that will directly assist in addressing our nations urgent need for qualified talent. 

In the past five years alone, the biopharmaceutical manufacturing industry has seen a 25% growth rate in employment accelerated during the peak of the COVID-19 pandemic. “We knew there was a large demand of talent in the industry and the pandemic magnified that. Gaps in the manufacturing process due to staffing could significantly contribute to the acceleration of bringing quality products to patients faster,” says John Balchunas, NIIMBL’s workforce development director. 

To address the urgent national need to fill jobs quickly, NIIMBL assembled leaders in academia and industry, from Solano College, Texas A&M, Pfizer, and North Carolina Biotechnology Center, to identify the problems with traditional hiring process and brainstorm innovative solutions. 

Released October 25, 2022, Updated October 26, 2022